Cranbrook Wealth Management’s Merck MRK Stock Holding History

Cranbrook Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$538K	Hold	4,475	–	–	0.11%	81
2025 Q4	$471K	Buy	4,475 +464	+12%	+$43.6K	0.09%	85
2025 Q3	$337K	Buy	4,011 +478	+14%	+$39.4K	0.07%	97
2025 Q2	$280K	Sell	3,533 -21	-0.6%	-$1.67K	0.06%	101
2025 Q1	$319K	Sell	3,554 -3,156	-47%	-$295K	0.07%	94
2024 Q4	$668K	Sell	6,710 -41	-0.6%	-$4.23K	0.15%	65
2024 Q3	$767K	Buy	6,751 +1,650	+32%	+$196K	0.17%	62
2024 Q2	$632K	Buy	5,101 +3,150	+161%	+$406K	0.16%	59
2024 Q1	$257K	Hold	1,951	–	–	0.07%	87
2023 Q4	$213K	Buy	1,951 +100	+5%	+$10.4K	0.06%	90
2023 Q3	$191K	Hold	1,851	–	–	0.06%	89
2023 Q2	$214K	Hold	1,851	–	–	0.06%	88
2023 Q1	$197K	Hold	1,851	–	–	0.06%	87
2022 Q4	$205K	Hold	1,851	–	–	0.06%	90
2022 Q3	$159K	Hold	1,851	–	–	0.04%	104
2022 Q2	$169K	Hold	1,851	–	–	0.04%	103
2022 Q1	$152K	Sell	1,851 -75	-4%	-$5.91K	0.03%	115
2021 Q4	$148K	Hold	1,926	–	–	0.03%	115
2021 Q3	$145K	Buy	1,926 +75	+4%	+$5.7K	0.03%	116
2021 Q2	$144K	Sell	1,851 -272	-13%	-$20.2K	0.03%	117
2021 Q1	$156K	Buy	2,123 +183	+9%	+$13.5K	0.04%	111
2020 Q4	$151K	Hold	1,940	–	–	0.04%	104
2020 Q3	$154K	Hold	1,940	–	–	0.04%	96
2020 Q2	$143K	Hold	1,940	–	–	0.04%	94
2020 Q1	$142K	Hold	1,940	–	–	0.05%	89
2019 Q4	$168K	Sell	1,940 -744	-28%	-$61.1K	0.05%	90
2019 Q3	$216K	Buy	2,684 +168	+7%	+$13.5K	0.06%	82
2019 Q2	$201K	Hold	2,516	–	–	0.06%	82
2019 Q1	$200K	Hold	2,516	–	–	0.06%	75
2018 Q4	$183K	Hold	2,516	–	–	0.06%	75
2018 Q3	$170K	Hold	2,516	–	–	0.06%	70
2018 Q2	$146K	Hold	2,516	–	–	0.06%	74
2018 Q1	$131K	Hold	2,516	–	–	0.05%	79
2017 Q4	$135K	Hold	2,516	–	–	0.05%	77
2017 Q3	$154K	Hold	2,516	–	–	0.06%	71
2017 Q2	$154K	Hold	2,516	–	–	0.07%	71
2017 Q1	$153K	Sell	2,516 -315	-11%	-$19.1K	0.07%	64
2016 Q4	$159K	Buy	2,831 +315	+13%	+$18.4K	0.08%	65
2016 Q3	$150K	Hold	2,516	–	–	0.08%	63
2016 Q2	$138K	Hold	2,516	–	–	0.07%	66
2016 Q1	$127K	Hold	2,516	–	–	0.07%	68
2015 Q4	$127K	Hold	2,516	–	–	0.07%	65
2015 Q3	$119K	Hold	2,516	–	–	0.07%	66
2015 Q2	$137K	Hold	2,516	–	–	0.08%	64
2015 Q1	$138K	Buy	2,516 +200	+9%	+$11.3K	0.08%	66
2014 Q4	$126K	Buy	+2,316	New	+$129K	0.08%	71
2014 Q1	–	Sell	-3,888	Closed	-$186K	–	197
2013 Q4	$186K	Buy	+3,888	New	+$178K	0.13%	57

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cranbrook Wealth Management's MRK Position: Q1 2026 in Review

Cranbrook Wealth Management held its Merck (MRK) position steady in Q1 2026 at 4,475 shares worth $538K. The position accounts for 0.11% of the portfolio, ranked #81.

Cranbrook Wealth Management first reported a position in MRK in Q4 2013 and has held it in 47 quarters since. The position peaked at $767K in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Cranbrook Wealth Management held 4,475 shares of Merck worth $538K as of Q1 2026.
Cranbrook Wealth Management left its Merck share count unchanged in Q1 2026.
Merck made up 0.11% of Cranbrook Wealth Management's portfolio in Q1 2026, its #81 holding.
Cranbrook Wealth Management first reported a position in Merck in Q4 2013 and has held it in 47 quarters since.
Cranbrook Wealth Management's Merck position peaked at $767K in Q3 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cranbrook Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.